SCR-LIP-000718 · Claim · machine-readable JSON →

The overall diagnostic performance of imaging for lipedema remains limited, with inconsistent protocols and no single validated objective test.

General proposition consolidated from 6 earlier single-paper claims; each study's own result is shown as its finding.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
moderate (GRADE)
Evidence
6 source(s)
Dates
2026-11-20 → 2026-11-20

Structured evidence, machine-compiled — not a verdict.

Evidence over time

20232026Lipedema: What we don’t know — van la Parra et al. (2023) · consistentDiagnostic imaging in lipedema: A systematic review — van la Parra et al. (2024) · consistentAssessment Tools to Quantify the Physical Aspects of Lipedema: A Systematic Review — Eason et al. (2025) · consistentThe Challenge of a Qualitative Ultrasonographic Classification in Lipedema — Vargas et al. (2025) · contextualLipedema Diagnosis, Clinical Manifestations, and Therapeutics: A Systematic Review — Vazirnia et al. (2026) · consistentLipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · refining

Evidence (6)

Context (PECO)

Populationwomen with suspected or confirmed lipedema
Conditionlipedema
Exposuremultimodal imaging (ultrasound, lymphoscintigraphy, CT, MRI, MR lymphangiography, DXA)
Outcomediagnostic performance for lipedema characterization
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Change log